Seung Il Kim

Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial

S. Ahn, Y. Jung, S. Im, 2023, Journal of Clinical Oncology.

Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic Breast Cancer

Min Hwan Kim, H. Park, Seho Park, 2023, Cancer research and treatment.